Ausgabe 3/2011
Inhalt (33 Artikel)
Endoscopic breast surgery: where are we now and what might the future hold for video-assisted breast surgery?
Daniel Richard Leff, Rajiv Vashisht, Gabriella Yongue, Mohammed Keshtgar, Guang-Zhong Yang, Ara Darzi
Triple negative breast cancer: unmet medical needs
Sumanta Kumar Pal, Barrett H. Childs, Mark Pegram
Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer
Marcus Schmidt, Ilka Brigitte Petry, Daniel Böhm, Antje Lebrecht, Christian von Törne, Susanne Gebhard, Aslihan Gerhold-Ay, Cristina Cotarelo, Marco Battista, Wiebke Schormann, Evgenia Freis, Silvia Selinski, Katja Ickstadt, Jörg Rahnenführer, Martin Sebastian, Martin Schuler, Heinz Koelbl, Mathias Gehrmann, Jan G. Hengstler
Breast cancer prognostic markers in the post-genomic era
Lajos Pusztai, Takayuki Iwamoto
Mutations and polymorphic BRCA variants transmission in breast cancer familial members
Brunella Pilato, Marianna Martinucci, Katia Danza, Rosamaria Pinto, Daniela Petriella, Rosanna Lacalamita, Michele Bruno, Rossana Lambo, Cosimo D’Amico, Angelo Paradiso, Stefania Tommasi
Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells
Stephen Hiscox, Peter Barnfather, Edd Hayes, Pamela Bramble, James Christensen, Robert I. Nicholson, Peter Barrett-Lee
COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients
Johanna G. H. van Nes, Esther M. de Kruijf, Dana Faratian, Cornelis J. H. van de Velde, Hein Putter, Claire Falconer, Vincent T. H. B. M. Smit, Charlene Kay, Marc J. van de Vijver, Peter J. K. Kuppen, John M. S. Bartlett
Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients
Esther M. de Kruijf, Johanna G. H. van Nes, Cornelis J. H. van de Velde, Hein Putter, Vincent T. H. B. M. Smit, Gerrit Jan Liefers, Peter J. K. Kuppen, Rob A. E. M. Tollenaar, Wilma E. Mesker
Genomics, histopathology, and the tumor microenvironment: new relationship or old friends re-discovered?
Daniel W. Visscher
Involvement of MyoD and c-myb in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene
Wei Jin, Yang Liu, Li Chen, Hua Zhu, Gen-hong Di, Hong Ling, Jiong Wu, Zhi-ming Shao
Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes
Xiao-Hua Zeng, Zhou-Luo Ou, Ke-Da Yu, Lan-Yun Feng, Wen-Jing Yin, Jing Li, Zhen-Zhou Shen, Zhi-Ming Shao
Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern
Katharina E. Effenberger, Elin Borgen, Christine zu Eulenburg, Kai Bartkowiak, Andrea Grosser, Marit Synnestvedt, Rolf Kaaresen, Burkhard Brandt, Jahn M. Nesland, Klaus Pantel, Bjorn Naume
Anastrozole and letrozole: an investigation and comparison of quality of life and tolerability
J. Michael Dixon, Lorna Renshaw, Carolyn Langridge, Oliver E. Young, Mary McHugh, Linda Williams, Juliette Murray, E. Jane Macaskill, Fiona McCaig, Oliver M. Dixon, Lesley J. Fallowfield
One size does not fit all: quality of life during adjuvant aromatase inhibitor therapy
N. Lynn Henry, Vered Stearns
Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies
Henri Roché, Pierfranco Conte, Edith A. Perez, Joseph A. Sparano, Binghe Xu, Jacek Jassem, Ronald Peck, Thomas Kelleher, Gabriel N. Hortobagyi
Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy
Dawn L. Hershman, Louis H. Weimer, Antai Wang, Grace Kranwinkel, Lois Brafman, Deborah Fuentes, Danielle Awad, Katherine D. Crew
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1–3 node-positive rapidly proliferating breast cancer
Dino Amadori, Rosella Silvestrini, Mario De Lena, Francesco Boccardo, Andrea Rocca, Emanuela Scarpi, Francesco Schittulli, Mario Brandi, Roberta Maltoni, Patrizia Serra, Riccardo Ponzone, Nicoletta Biglia, Lorenzo Gianni, Amelia Tienghi, Maria Rosaria Valerio, Paola Bonginelli, Laura Amaducci, Marina Faedi, Editta Baldini, Angelo Paradiso
Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer
Takayuki Iwamoto, Giampaolo Bianchini, Yuan Qi, Massimo Cristofanilli, Anthony Lucci, Wendy A. Woodward, James M. Reuben, Junji Matsuoka, Yun Gong, Savitri Krishnamurthy, Vicente Valero, Gabriel N. Hortobagyi, Fredika Robertson, W. Fraser Symmans, Lajos Pusztai, Naoto T. Ueno
Evaluation of estrogen and progesterone receptors in non-neoplastic breast tissue of women of reproductive age exposed to tamoxifen and raloxifene: a randomized, double-blind study
Marta Alves Rosal, Benedito Borges da Silva
Outcomes following local therapy for early-stage breast cancer in non-trial populations
Nancy L. Keating, Mary Beth Landrum, John M. Brooks, Elizabeth A. Chrischilles, Eric P. Winer, Kara Wright, Rita Volya
Supraclavicular recurrence after early breast cancer: a curable condition?
Anders N. Pedersen, Susanne Møller, Karina D. Steffensen, Vera Haahr, Merete Jensen, Mette M. Kempel, Søren L. Jepsen, Ebbe L. Madsen, Anne Roslind, Erik Sandberg, Claudia Schöllkopf, Peter G. Sørensen, Karen Margrethe Windfeldt, Michael Andersson
Breast cancer in the supraclavicular region: is the horse out of the barn?
Reshma Jagsi
RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies
Lin-Bo Gao, Xin-Min Pan, Li-Juan Li, Wei-Bo Liang, Yi Zhu, Lu-Shun Zhang, Yong-Gang Wei, Ming Tang, Lin Zhang
Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers
Victor R. Grann, Priya R. Patel, Judith S. Jacobson, Ellen Warner, Daniel F. Heitjan, Maxine Ashby-Thompson, Dawn L. Hershman, Alfred I. Neugut
Association of a vascular endothelial growth factor gene 936 C/T polymorphism with breast cancer risk: a meta-analysis
Dae Sik Yang, Kyong Hwa Park, Ok Hee Woo, Sang Uk Woo, Ae-Ree Kim, Eun Sook Lee, Jae-Bok Lee, Yeul Hong Kim, Jun Suk Kim, Jae Hong Seo
The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers
Irene Catucci, Paolo Verderio, Sara Pizzamiglio, Siranoush Manoukian, Bernard Peissel, Daniela Zaffaroni, Gaia Roversi, Carla B. Ripamonti, Barbara Pasini, Monica Barile, Alessandra Viel, Giuseppe Giannini, Laura Papi, Liliana Varesco, Aline Martayan, Mirko Riboni, Sara Volorio, Paolo Radice, Paolo Peterlongo
Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes
Madhura S. Mehta, Alexei Vazquez, Diptee A. Kulkarni, John E. Kerrigan, Gurinder Atwal, Shoichi Metsugi, Deborah L. Toppmeyer, Arnold J. Levine, Kim M. Hirshfield
Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study
Daniel Prieto-Alhambra, M. Kassim Javaid, Sonia Servitja, Nigel K. Arden, Maria Martinez-García, Adolfo Diez-Perez, Joan Albanell, Ignasi Tusquets, Xavier Nogues
Gene expression array testing of FFPE archival breast tumor samples: an optimized protocol for WG-DASL® sample preparation
C. C. Ton, N. Vartanian, X. Chai, M. G. Lin, X. Yuan, K. E. Malone, C. I. Li, A. Dawson, C. Sather, J. Delrow, L. Hsu, P. L. Porter
Two novel variants in the 3′UTR of the BRCA1 gene in familial breast and/or ovarian cancer
Stéphanie Lheureux, Bernard Lambert, Sophie Krieger, Angelina Legros, Dominique Vaur, Christophe Denoyelle, Pascaline Berthet, Laurent Poulain, Agnès Hardouin
A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance
A. Gabriella Wernicke, Robert L. Goodman, Bruce C. Turner, Lydia T. Komarnicky, Walter J. Curran, Paul J. Christos, Imraan Khan, Katherine Vandris, Bhupesh Parashar, Dattatreyudu Nori, K. S. Clifford Chao